Abstract |
Aristolochic acid nephropathy (AAN) is a progressive kidney disease caused by some Chinese herbal medicines, but treatment remains ineffective. Macrophage accumulation is an early feature in human and experimental AAN; however, the role of macrophages in chronic AAN is unknown. We report here that targeting macrophages with fms-I, a selective inhibitor of the tyrosine kinase activity of the macrophage colony-stimulating factor receptor, suppressed disease progression in a mouse model of chronic AAN. Treatment with fms-I (10mg/kg/BID) from day 0 to 28 (prevention study) or from day 14 to 28 (intervention study) substantially inhibited macrophage accumulation and significantly improved renal dysfunction including a reduction in proteinuria and tubular damage. Progressive interstitial fibrosis (myofibroblast accumulation and collagen deposition) and renal inflammation (increased expression of MCP-1, MIF, and TNF-α) were also attenuated by fms-I treatment. These protective effects involved inhibition of TGF-β/Smad3 and NF-kB signaling. In conclusion, the present study establishes that macrophages are key inflammatory cells that exacerbates progressive tubulointerstitial damage in chronic AAN via mechanisms associated with TGF-β/Smad3-mediated renal fibrosis and NF-κB-driven renal inflammation. Targeting macrophages via a c-fms kinase inhibitor may represent a novel therapy for chronic AAN.
|
Authors | Xiao Y Dai, Xiao R Huang, Li Zhou, Lin Zhang, Ping Fu, Carl Manthey, David J Nikolic-Paterson, Hui Y Lan |
Journal | Oncotarget
(Oncotarget)
Vol. 7
Issue 10
Pg. 10841-56
(Mar 08 2016)
ISSN: 1949-2553 [Electronic] United States |
PMID | 26909597
(Publication Type: Journal Article)
|
Chemical References |
- Aristolochic Acids
- Protein Kinase Inhibitors
- Receptor, Macrophage Colony-Stimulating Factor
|
Topics |
- Animals
- Aristolochic Acids
(toxicity)
- Disease Models, Animal
- Disease Progression
- Fibrosis
(chemically induced)
- Inflammation
(chemically induced, pathology)
- Kidney Diseases
(chemically induced, drug therapy, enzymology, pathology)
- Macrophages
(drug effects, metabolism, pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Protein Kinase Inhibitors
(pharmacology)
- Receptor, Macrophage Colony-Stimulating Factor
(antagonists & inhibitors)
- Signal Transduction
|